New Zealand Public Health and Disability Act 2000

50 Board of Pharmac to establish advisory committees

(1)

The board of Pharmac must establish the following advisory committees under clause 14(1)(a) of Schedule 5 of the Crown Entities Act 2004:

(a)

a pharmacology and therapeutics advisory committee to provide objective advice to Pharmac on pharmaceuticals and their benefits:

(b)

a consumer advisory committee to provide input from a consumer or patient point of view.

(2)

[Repealed]

(3)

[Repealed]

(4)

Despite clause 14(1)(a) of Schedule 5 of the Crown Entities Act 2004, the members of the pharmacology and therapeutics advisory committee are appointed by the Director-General in consultation with the board of Pharmac.

Section 50(1): amended, on 25 January 2005, by section 200 of the Crown Entities Act 2004 (2004 No 115).

Section 50(2): repealed, on 25 January 2005, by section 200 of the Crown Entities Act 2004 (2004 No 115).

Section 50(3): repealed, on 25 January 2005, by section 200 of the Crown Entities Act 2004 (2004 No 115).

Section 50(4): amended, on 25 January 2005, by section 200 of the Crown Entities Act 2004 (2004 No 115).